Acute and chronic nicotine exposure differentially facilitate the induction of LTP

Brain Research

Volumn 846, Issue 1, 1999, Pages 137-143

  Fujii, Satoshi ^a   Ji, Zhanxin ^a   Morita, Naonori ^a   Sumikawa, Katumi ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hippocampus; Long term potentiation; Nicotine; Nicotinic acetylcholine receptor

Indexed keywords

NICOTINE; NICOTINIC RECEPTOR; NOOTROPIC AGENT;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; LONG TERM POTENTIATION; MEMORY; NONHUMAN; PRIORITY JOURNAL; RAT; SMOKING; STIMULATION;

ACTION POTENTIALS; ANIMALS; COGNITION; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; LONG-TERM POTENTIATION; MECAMYLAMINE; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; ORGAN CULTURE TECHNIQUES; RATS; RECEPTORS, NICOTINIC;

EID: 0032852717     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01982-4     Document Type: Article

References (22)

1. Abdulla F.A., Calaminici M.-R., Stephenson J.D., Sinden J.D. Chronic treatment with cholinoceptor drugs influences spatial learning in rats. Psychopharmacology. 111:1993;508-511.
2. Abdulla F.A., Bradbury E., Calaminici M.-R., Lippiello P.M., Wonnacott S., Gray J.A., Sinden J.D. Relationship between up-regulation of nicotine binding sites in rat brain and delayed cognitive enhancement observed after chronic or acute nicotinic receptor stimulation. Psychopharmacology. 124:1996;323-331.
3. Arai A., Guidotti A., Costa E., Lynch G. Effect of the AMPA receptor modulator IDRA 21 on LTP in hippocampal slices. NeuroReport. 7:1996;2211-2215.
4. Bliss T.V.P., Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anesthetized rabbit following stimulation of the perforant path. J. Physiol. 232:1973;331-356.
5. Bliss T.V.P., Gardner-Medwin A.R. Long-lasting potentiation of synaptic transmission in the dentate area of the unanesthetized rabbit following stimulation of the perforant path. J. Physiol. 232:1973;357-374.
6. Brenner D.E., Kukull W.A., van Belle G., Bowen J.D., McCormick W.C., Teri L., Larson E.B. Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study. Neurology. 43:1993;293-300.
7. Collins A.C., Romm E., Wehner J.M. Dissociation of the apparent relationship between nicotine tolerance and up-regulation of nicotinic receptors. Brain Res. Bull. 25:1990;373-379.
8. Court J.A., Perry E.K. CNS nicotinic receptors. Possible therapeutic targets in neurodegenerative disorders. CNS Drugs. 2:1994;216-233.
9. Dani J.A., Heinemann S. Molecular and cellular aspects of nicotine abuse. Neuron. 16:1996;905-908.
10. El-Bizri H., Clarke P.B.S. Regulation of nicotinic receptors in rat brain following quasi-irreversible nicotinic blockade by chlorisondamine and chronic treatment with nicotine. Br. J. Pharmacol. 113:1994;917-925.
11. Gray R., Rajan A.S., Radcliffe K.A., Yakehiro M., Dani J.A. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature. 383:1996;713-716.
12. Jones G.M.M., Sahakian B.J., Levy R., Warburton D.M., Gray J.A. Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology. 108:1992;485-494.
13. Lee P.N. Smoking and Alzheimer's disease: a review of the epidemiological evidence. Neuroepidemiology. 13:1994;131-144.
14. Levin E.D. Nicotine systems and cognitive function. Psychopharmacology. 108:1992;417-431.
15. Levin E.D. Nicotinic involvement in cognitive function: possible therapeutic applications. Med. Chem. Res. 2:1993;612-627.
16. Miller R.P., Rotenberg K.S., Adir J. Effect of dose on the pharmacokinetics of intravenous nicotine in the rat. Drug Metab. Dispos. 5:1977;436-443.
17. Morris R.G.M., Anderson E., Lynch G.S., Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature. 319:1986;774-776.
18. Newhouse P.A., Potter A., Lenox R.H. The effects of nicotinic agents on human cognition: possible therapeutic applications in Alzheimer's and Parkinson's diseases. Med. Chem. Res. 2:1993;628-642.
19. Pauly J.R., Marks M.J., Gross S.D., Collins A.C. An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment. J. Pharmacol. Exp. Ther. 258:1991;1127-1136.
20. Poincheval-Fuhrman S., Sara S.J. Chronic nicotine ingestion improves radial arm maze performance in rats. Behav. Pharmacol. 4:1993;535-539.
21. Sahakian B.J., Coull J.T. Nicotine and tetrahydroaminoacridine: evidence for improved attention in patients with dementia of the Alzheimer type. Drug Dev. Res. 31:1994;80-88.
22. Staubli U., Perrez Y., Xu F.B., Rogers G., Ingvar M., Stone-Elander S., Lynch G. Centrally active modulators of glutamate receptors facilitate the induction of long-term potentiation in vivo. Proc. Natl. Acad. Sci. U.S.A. 91:1994;11158-11162.